A new critical role of ceRNAs in ER + breast cancer is proposed.
We examine the relationship of CYP4Z2P, CYP4Z1 and CDK3 in breast cancer.
The roles of CYP4Z2P and CYP4Z1 in TAM resistance were further studied.
The novel mechanism provides new insights for TAM resistance.